Display options
Share it on

Curr Opin Toxicol. 2017 Feb;2:36-41. doi: 10.1016/j.cotox.2017.01.010. Epub 2017 Feb 01.

Beyond the Aryl Hydrocarbon Receptor: Pathway Interactions in the Hepatotoxicity of 2,3,7,8-Tetrachlorodibenzo-.

Current opinion in toxicology

Kelly A Fader, Timothy R Zacharewski

Affiliations

  1. Department of Biochemistry & Molecular Biology, Michigan State University, East Lansing, MI, 48824.
  2. Institute for Integrative Toxicology, Michigan State University, East Lansing, MI, 48824.

PMID: 28948239 PMCID: PMC5609723 DOI: 10.1016/j.cotox.2017.01.010

Abstract

2,3,7,8-Tetrachlorodibenzo-

Keywords: Aryl hydrocarbon receptor; Hepatotoxicity; Metabolic Reprogramming; Species-Specific Sensitivity; Toxicogenomics

References

  1. Toxicol Sci. 2012 Jan;125(1):41-55 - PubMed
  2. Toxicol Sci. 2013 May;133(1):54-66 - PubMed
  3. JAMA. 1963 Jan 12;183:88-91 - PubMed
  4. Toxicol Sci. 2013 Jun;133(2):197-208 - PubMed
  5. BMC Genomics. 2008 Sep 16;9:419 - PubMed
  6. Drug Metab Rev. 2016 Aug;48(3):342-50 - PubMed
  7. Toxicol Sci. 2016 Feb;149(2):358-71 - PubMed
  8. Environ Health Insights. 2016 Aug 17;10:133-41 - PubMed
  9. Nature. 2011 Oct 05;478(7368):197-203 - PubMed
  10. Res Commun Chem Pathol Pharmacol. 1973 Nov;6(3):919-28 - PubMed
  11. Environ Health Perspect. 2015 Jul;123(7):679-88 - PubMed
  12. BMC Genomics. 2006 Apr 12;7:80 - PubMed
  13. Pharmacogenetics. 1993 Oct;3(5):213-30 - PubMed
  14. Toxicol Sci. 2012 May;127(1):199-215 - PubMed
  15. Toxicol Appl Pharmacol. 1984 Jun 15;74(1):17-25 - PubMed
  16. Toxicol Sci. 2006 Dec;94(2):398-416 - PubMed
  17. Crit Rev Toxicol. 1990;21(1):51-88 - PubMed
  18. Drug Chem Toxicol. 1988;11(1):55-70 - PubMed
  19. Sci Rep. 2017 Jul 19;7(1):5921 - PubMed
  20. Blood Cells Mol Dis. 2011 Dec 15;47(4):249-54 - PubMed
  21. Hepatology. 2012 Jun;55(6):1994-2004 - PubMed
  22. Toxicol Sci. 2009 Nov;112(1):257-72 - PubMed
  23. Cell Metab. 2016 Jan 12;23 (1):27-47 - PubMed
  24. BMC Genomics. 2011 Apr 15;12 :193 - PubMed
  25. Chem Res Toxicol. 2011 Apr 18;24(4):494-504 - PubMed
  26. Mol Pharmacol. 1998 Jan;53(1):52-61 - PubMed
  27. Toxicol Appl Pharmacol. 2013 Mar 1;267(2):184-91 - PubMed
  28. Mol Pharmacol. 2012 Mar;81(3):338-47 - PubMed
  29. Toxicol Sci. 2009 Oct;111(2):238-46 - PubMed
  30. Toxicol Sci. 2016 Dec;154(2):253-266 - PubMed
  31. Toxicol Appl Pharmacol. 2008 Mar 1;227(2):196-206 - PubMed
  32. Toxicol Sci. 2006 Oct;93(2):223-41 - PubMed
  33. Toxicol Sci. 2014 Jan;137(1):114-24 - PubMed
  34. Annu Rev Pharmacol Toxicol. 2003;43:309-34 - PubMed
  35. BMC Genomics. 2011 Jul 15;12 :365 - PubMed
  36. Crit Rev Eukaryot Gene Expr. 2008;18(3):207-50 - PubMed
  37. Toxicol Sci. 2011 Nov;124(1):1-22 - PubMed
  38. Environ Health Perspect. 2011 Dec;119(12):1739-44 - PubMed
  39. Arch Dermatol. 1964 Jun;89:793-7 - PubMed
  40. Am J Ind Med. 1994 Apr;25(4):559-71 - PubMed
  41. Toxicol Appl Pharmacol. 2017 Apr 15;321:1-17 - PubMed
  42. Toxicol Appl Pharmacol. 2001 Jun 1;173(2):89-98 - PubMed
  43. Annu Rev Pharmacol Toxicol. 1995;35:307-40 - PubMed
  44. Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5079-84 - PubMed
  45. Annu Rev Pharmacol Toxicol. 1982;22:517-54 - PubMed
  46. Biochem Pharmacol. 2000 Jan 1;59(1):65-85 - PubMed
  47. Science. 1979 Apr 20;204(4390):332-5 - PubMed
  48. Toxicol Sci. 2005 Oct;87(2):508-19 - PubMed

Publication Types

Grant support